These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19299309)

  • 1. Risk factors associated with major cerebrovascular complications after intracranial stenting.
    Nahab F; Lynn MJ; Kasner SE; Alexander MJ; Klucznik R; Zaidat OO; Chaloupka J; Lutsep H; Barnwell S; Mawad M; Lane B; Chimowitz MI;
    Neurology; 2009 Jun; 72(23):2014-9. PubMed ID: 19299309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The learning curve for neuroendovascular procedures: how important is it?
    Chaturvedi S; Dumont AS
    Neurology; 2009 Jun; 72(23):1974-5. PubMed ID: 19403883
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of Stenting Plus Medical Therapy vs Medical Therapy Alone on Risk of Stroke and Death in Patients With Symptomatic Intracranial Stenosis: The CASSISS Randomized Clinical Trial.
    Gao P; Wang T; Wang D; Liebeskind DS; Shi H; Li T; Zhao Z; Cai Y; Wu W; He W; Yu J; Zheng B; Wang H; Wu Y; Dmytriw AA; Krings T; Derdeyn CP; Jiao L;
    JAMA; 2022 Aug; 328(6):534-542. PubMed ID: 35943472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the Stenting Versus Aggressive Medical Therapy Trial Support Stenting for Subgroups With Intracranial Stenosis?
    Lutsep HL; Lynn MJ; Cotsonis GA; Derdeyn CP; Turan TN; Fiorella D; Janis LS; Lane BF; Montgomery J; Chimowitz MI;
    Stroke; 2015 Nov; 46(11):3282-4. PubMed ID: 26382173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do patients with basilar or vertebral artery stenosis have a higher stroke incidence poststenting?
    Jiang WJ; Du B; Hon SF; Jin M; Xu XT; Ma N; Gao F; Dong KH
    J Neurointerv Surg; 2010 Mar; 2(1):50-4. PubMed ID: 21990559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcarotid artery revascularization versus transfemoral carotid artery stenting in the Society for Vascular Surgery Vascular Quality Initiative.
    Malas MB; Dakour-Aridi H; Wang GJ; Kashyap VS; Motaganahalli RL; Eldrup-Jorgensen J; Cronenwett JL; Schermerhorn ML
    J Vasc Surg; 2019 Jan; 69(1):92-103.e2. PubMed ID: 29941316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of qualifying artery on the efficacy of stenting plus medical therapy versus medical therapy alone in patients with symptomatic intracranial stenosis: a post-hoc analysis of the CASSISS trial.
    Wu Q; Wang J; Zheng B; Qi J; Xu S; Wu P; Zhang G; Ji Z; Wang C; Yao J; Jiao L; Gao P; Wang T; Wang D; Li T; He Y; Zhao Z; Cai Y; Wu W; He W; Shi H; Li Y;
    J Neurointerv Surg; 2024 Jun; 16(7):663-669. PubMed ID: 37438104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stenting versus medical treatment in patients with symptomatic vertebral artery stenosis: a randomised open-label phase 2 trial.
    Compter A; van der Worp HB; Schonewille WJ; Vos JA; Boiten J; Nederkoorn PJ; Uyttenboogaart M; Lo RT; Algra A; Kappelle LJ;
    Lancet Neurol; 2015 Jun; 14(6):606-14. PubMed ID: 25908089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors Associated With Recurrent Ischemic Stroke in the Medical Group of the SAMMPRIS Trial.
    Waters MF; Hoh BL; Lynn MJ; Kwon HM; Turan TN; Derdeyn CP; Fiorella D; Khanna A; Sheehan TO; Lane BF; Janis S; Montgomery J; Chimowitz MI;
    JAMA Neurol; 2016 Mar; 73(3):308-15. PubMed ID: 26747792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stenting for symptomatic intracranial arterial stenosis in China: 1-year outcome of a multicentre registry study.
    Ma N; Zhang Y; Shuai J; Jiang C; Zhu Q; Chen K; Liu L; Li B; Shi X; Gao L; Liu Y; Wang F; Li Y; Liu T; Zheng H; Mo D; Gao F; Wang Y; Wang Y; Feng L; Miao Z
    Stroke Vasc Neurol; 2018 Sep; 3(3):176-184. PubMed ID: 30294474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. China Angioplasty and Stenting for Symptomatic Intracranial Severe Stenosis (CASSISS): A new, prospective, multicenter, randomized controlled trial in China.
    Gao P; Zhao Z; Wang D; Wu J; Cai Y; Li T; Wu W; Shi H; He W; Zhu F; Jiao L; Ling F
    Interv Neuroradiol; 2015 Apr; 21(2):196-204. PubMed ID: 25934656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial.
    Zaidat OO; Fitzsimmons BF; Woodward BK; Wang Z; Killer-Oberpfalzer M; Wakhloo A; Gupta R; Kirshner H; Megerian JT; Lesko J; Pitzer P; Ramos J; Castonguay AC; Barnwell S; Smith WS; Gress DR;
    JAMA; 2015 Mar 24-31; 313(12):1240-8. PubMed ID: 25803346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of antithrombotic therapy and risk of stroke in patients with symptomatic intracranial stenosis.
    Turan TN; Maidan L; Cotsonis G; Lynn MJ; Romano JG; Levine SR; Chimowitz MI;
    Stroke; 2009 Feb; 40(2):505-9. PubMed ID: 19095991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stenting for symptomatic vertebral artery stenosis: The Vertebral Artery Ischaemia Stenting Trial.
    Markus HS; Larsson SC; Kuker W; Schulz UG; Ford I; Rothwell PM; Clifton A;
    Neurology; 2017 Sep; 89(12):1229-1236. PubMed ID: 28835400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vertebral artery stenting to prevent recurrent stroke in symptomatic vertebral artery stenosis: the VIST RCT.
    Markus HS; Larsson SC; Dennis J; Kuker W; Schulz UG; Ford I; Clifton A; Rothwell PM
    Health Technol Assess; 2019 Aug; 23(41):1-30. PubMed ID: 31422789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stenting for symptomatic vertebral artery stenosis: a preplanned pooled individual patient data analysis.
    Markus HS; Harshfield EL; Compter A; Kuker W; Kappelle LJ; Clifton A; van der Worp HB; Rothwell P; Algra A;
    Lancet Neurol; 2019 Jul; 18(7):666-673. PubMed ID: 31130429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complexity of Aortic Arch Anatomy Affects the Outcomes of Transcarotid Artery Revascularization Versus Transfemoral Carotid Artery Stenting.
    Conway AM; Nguyen Tran NT; Qato K; Ehidom C; Stoffels GJ; Giangola G; Carroccio A
    Ann Vasc Surg; 2020 Aug; 67():78-89. PubMed ID: 32339690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the management of symptomatic vertebral artery stenosis.
    Drazyk AM; Markus HS
    Curr Opin Neurol; 2018 Feb; 31(1):1-7. PubMed ID: 29084065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors associated with in-hospital serious adverse events after stenting of severe symptomatic intracranial stenosis.
    Cheng L; Jiao L; Gao P; Song G; Chen S; Wang X; Ren X
    Clin Neurol Neurosurg; 2016 Aug; 147():59-63. PubMed ID: 27295603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CAPTURE registry: predictors of outcomes in carotid artery stenting with embolic protection for high surgical risk patients in the early post-approval setting.
    Gray WA; Yadav JS; Verta P; Scicli A; Fairman R; Wholey M; Hopkins LN; Atkinson R; Raabe R; Barnwell S; Green R;
    Catheter Cardiovasc Interv; 2007 Dec; 70(7):1025-33. PubMed ID: 18044758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.